25 Nov, EOD - Indian

SENSEX 80109.85 (1.25)

Nifty 50 24221.9 (1.32)

Nifty Bank 52207.5 (2.10)

Nifty IT 43618.15 (0.66)

Nifty Midcap 100 55900.55 (1.61)

Nifty Next 50 69342.7 (1.95)

Nifty Pharma 22177.05 (0.98)

Nifty Smallcap 100 18115.85 (2.03)

25 Nov, EOD - Global

NIKKEI 225 38780.14 (1.30)

HANG SENG 19150.99 (-0.41)

S&P 5990.56 (0.27)

Login/Signup
LOGIN HERE
Cancel

Medplus Health Services Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543427 | NSE Symbol : MEDPLUS | ISIN : INE804L01022 | Industry : Retail |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
10-Oct-2024 12-Nov-2024 Quarterly Results Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended September 30 2024. Outcome of the Board Meeting held on November 12, 2024 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As per BSE Announcement dated on 12/11/2024)
27-Jun-2024 02-Aug-2024 Quarterly Results Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2024.under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 & Trading Window Closure under SEBI (Prohibition of Insider Trading)Regulations 2015 Outcome of Board Meeting held on August 2, 2024 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement dated on 02.08.2024)
01-Jul-2024 01-Jul-2024 Change in Directors Outcome of Board Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
30-Mar-2024 28-May-2024 Accounts Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2024 Outcome of the Board Meeting held on May 28, 2024 under Regulation 30 of SEBI( Listing Obligations and Disclosure) Requirements) Regulations, 2015 Outcome of the Board Meeting held on May 28, 2024, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR') (As Per BSE Announcement Dated on 28.05.2024)
16-Feb-2024 21-Feb-2024 Qualified Institutions Placements Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/02/2024 inter alia to consider and approve to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30 2023. Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of the Company (As Per BSE Announcement Dated on 21.02.2024)
27-Dec-2023 02-Feb-2024 Quarterly Results Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter ended December 31 2023. Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 and Companys Code of Conduct for Prevention of Insider Trading the trading window for the Designated Employees Directors and their relatives will remain closed from January 1 2024 to February 4 2024 i.e 48 hours of declaration of results to the Stock Exchanges. Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR') of the Company Outcome of Board Meeting under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulations, 2015 of the Company (As Per BSE Announcement dated on 02.02.2024)
09-Oct-2023 08-Nov-2023 Quarterly Results Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2023 ,inter alia, to consider and approve Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Un-audited financial results for the quarter and half year ended September 30, 2023 (As Per BSE Announcement dated on 25.10.2023) Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of the Company (As Per BSE Announcement Dated on 08/11/2023) Intimation regarding newspaper publication of Extract of un-audited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2023 (As Per BSE Announcement dated on 09.11.2023)
26-Oct-2023 26-Oct-2023 Change in Directors Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR') of the Company.
06-Oct-2023 11-Oct-2023 Raising funds through Debt Instr. Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2023 inter alia to consider and approve proposal for raising of funds by the Company pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended ('SEBI Listing Regulations') Outcome of Board Meeting pursuant to Regulation 30 of SEBI ( LODR) regulations, 2015 (As per BSE Announcement Dated on 11/10/2023)
30-Sep-2023 05-Oct-2023 Raising funds through Debt Instr. Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/10/2023 inter alia to consider and approve Proposal for raising of funds by the Company Outcome of Board Meeting pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015 (As Per BSE Announcement Dated on 05.10.2023)
21-Sep-2023 21-Sep-2023 Change in Auditors Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
07-Jul-2023 07-Aug-2023 Quarterly Results Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2023 inter alia to consider and approve MedPlus Health Services Limited has informed BSE that the meeting of Board of Director is scheduled on August 01 2023 for approval of un-audited Financial Statement. MEDPLUS HEALTH SERVICES LIMITED has informed BSE about Board Meeting to be held on 01 Aug 2023 to consider financial statements for the period ended June 2024. Financial results. The Board Meeting to be held on 01/08/2023 has been revised to 07/08/2023 Revised date of Board Meeting under Regulation 29, of SEBI (LODR) Regulation, 2015 (As Per BSE Announcement dated on 10.07.2023) Outcome of Board meeting under Regulation 30 and 30(4) read with Para A & B of Part A of Schedule III of SEBI( LODR) Regulations, 2015 of the Company held today i.e August 07, 2023. (As per BSE Announcement Dated on 07/08/2023)
03-May-2023 25-May-2023 Accounts Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2023 inter alia to consider and approve The Company has intimated the Exchange under Regulation 29 of SEBI (LODR) 2015 of Board Meeting scheduled to be held on Thursday May 25 2023to consider Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2023 This is to inform you that the Board of Directors of the Company at its Meeting held on May 25, 2023 have approved and taken record of the audited Standalone and Consolidated Financial Results of the Company for the Fourth Quarter and Financial Year ended March 31, 2023. (As per BSE Announcement Dated on 25/05/2023)
25-Apr-2023 11-May-2023 Postal Ballot Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2023 inter alia to consider and approve The Company has informed the Exchange Board Meeting scheduled to be held on 11th May 2023 to consider for approval of Members through Postal Ballot for 2 Business matters The Company has informed the exchange regarding Outcome of Board meeting held on May 11, 2023 (As Per BSE Announcement Dated on 12.05.2023)
13-Jan-2023 03-Feb-2023 Quarterly Results Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations 2015) please be informed that the Meeting of the Board of Directors of the Company will be held on Friday 3rd February 2023 to inter alia consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the Third Quarter and nine months ended 31st December 2022. The company intimates the Unaudited Standalone and Consolidated Financial Results of the Company for the third quarter and nine months ended 31st December, 2022, along with the Limited Review Report thereon, issued by the Statutory Auditors, M/s B S R & Associates LLP, Chartered Accountants. This is to inform you that the Board of Directors of the Company at its Meeting held on 3rd February, 2023 have approved the Unaudited Standalone and Consolidated Financial Results of the Company for the third quarter and nine months ended on 31st December, 2022. This is intimation pursuant to Regulations 30, 33, read with Para A. 4. (h) of Part A and Para A. (16) (b) of Part B of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). We are enclosing the Unaudited Standalone and Consolidated Financial Results of the Company for the third quarter and nine months ended 31st December, 2022, along with the Limited Review Report thereon, issued by the Statutory Auditors, M/s B S R & Associates LLP, Chartered Accountants. (As Per BSE Announcement Dated on 03/02/2023)
1 2